Document is current
Any future updates will be listed below
-
Authors
Benavides-Villanueva, Fabricio https://orcid.org/0000-0003-2401-3781
Gaitán-Valdizán, Jorge J. https://orcid.org/0000-0002-6903-8707
Fernández-Ramón, Raúl https://orcid.org/0000-0002-5616-371X
Martín-Varillas, José L. https://orcid.org/0000-0001-6147-6633
Mobarak, Armin https://orcid.org/0009-0001-0230-381X
Cifrián-Martínez, José https://orcid.org/0000-0003-3682-0142
Demetrio-Pablo, Rosalía https://orcid.org/0000-0002-0767-234X
Castañeda, Santos https://orcid.org/0000-0002-7748-853X
Blanco, Ricardo https://orcid.org/0000-0003-2344-2285
- License Information
-
More Information
Article History
Received: 13 March 2025
Accepted: 31 May 2025
First Online: 27 June 2025
Declarations
:
: Disclosures that might be interpreted as constituting of possible conflict(s) of interest for the study: Jorge Javier Gaitán-Valdizán received grants/research supports and payment for an expert testimony/advisory from GSK. Santos Castañeda has received grants/research supports from MSD, Pfizer, and UCB, and had consultation fees/participation in company-sponsored speaker’s bureau from Lilly, Gedeon-Richter, Janssen, Roche and UCB. Ricardo Blanco received grants/research supports from AbbVie, MSD, and Roche, and had consultation fees/participation in company-sponsored speaker’s bureau from AbbVie, Pfizer, Roche, Bristol-Myers, Janssen, Sanofi, Lilly and MSD. The following authors, Fabricio Benavides-Villanueva, Raúl Fernández-Ramón, José L. Martín-Varillas, Armin Mobarak, José Cifrián Martínez and Rosalía Demetrio-Pablo did not declare financial disclosures. Data reported in this manuscript were presented in part at the virtual 2021 EULAR Congress hold in Frankfurt, Germany, 2-5 June 2021.
